Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,678 | 4,609 | 8,386 | 6,080 | 2,649 |
| Marketable Securities | N/A | 2,866 | N/A | N/A | N/A |
| Receivables | 405 | 495 | 445 | 429 | 339 |
| Other current assets | 39 | 124 | 76 | 75 | 557 |
| TOTAL | $7,122 | $8,093 | $8,906 | $6,584 | $3,545 |
| Non-Current Assets | |||||
| PPE Net | 323 | 372 | 396 | 421 | 475 |
| Intangibles | 0 | 178 | 178 | 178 | 0 |
| Other Non-Current Assets | 31 | 32 | 40 | 23 | 91 |
| TOTAL | $354 | $582 | $615 | $622 | $566 |
| Total Assets | $7,476 | $8,675 | $9,521 | $7,206 | $4,111 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 388 | 193 | 287 | 355 | 266 |
| Accrued Expenses | 29 | 41 | 23 | 18 | 210 |
| Other current liabilities | N/A | N/A | 88 | 810 | N/A |
| TOTAL | $417 | $234 | $398 | $1,183 | $500 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 2 | 2 | 17 | 32 |
| TOTAL | $N/A | $2 | $2 | $17 | $32 |
| Total Liabilities | $417 | $236 | $400 | $1,200 | $532 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4 | 3 | 3 | 3 | 3 |
| Common Shares | 31 | 28 | 28 | 26 | 23 |
| Retained earnings | -51,873 | -48,689 | -47,591 | -45,911 | -43,724 |
| TOTAL | $7,059 | $8,439 | $9,121 | $6,006 | $3,579 |
| Total Liabilities And Equity | $7,476 | $8,675 | $9,521 | $7,206 | $4,111 |